FDA seeks probe into communications between staff and Biogen over Alzheimer's ...

FDA seeks probe into communications between staff and Biogen over Alzheimer's ...
FDA seeks probe into communications between staff and Biogen over Alzheimer's ...
BREAKING NEWS: FDA seeks probe into communications between its staff and Biogen after controversial approval of Alzheimer's drug FDA commissioner Janet Woodcock has asked for a probe into her staff's communications with Biogen Biogen's Aduhelm received FDA approval for Alzhiemer's disease in early June despite limited data that it worked in clinical trials  
PREV CDC issues new guidance calling for schools to fully reopen in the fall 
NEXT Oklahoma gymnastics facility at the center of a 21-case outbreak of Indian ...